CVS Health stock holds near USD 87.73 as earnings beat estimates

CVS Health Corp. (US1266501006) traded at USD 87.73 on the NYSE on September 22, 2026, after gaining USD 0.13 during mid-day trading. The price sits below the 52-week high of USD 110.68 and above the 52-week low of USD 69.51, while market capitalization stood at USD 112.21 billion.

Earnings beat consensus by USD 0.71

The latest reported quarter provides the clearest operating signal. According to MarketBeat on September 22, 2026, CVS Health posted adjusted earnings of USD 2.58 per share for the quarter reported on August 5, 2026. That result exceeded the USD 1.87 consensus estimate by USD 0.71 and rose from USD 1.81 in the same quarter of the prior year.

Revenue reached USD 106.10 billion in the quarter reported on August 5, 2026, compared with a consensus estimate of USD 100.03 billion. Revenue therefore exceeded the estimate by USD 6.07 billion and increased 7.3 percent from the comparable prior-year quarter, according to MarketBeat.

Guidance sets the valuation test

Management's fiscal-year 2026 earnings guidance was listed at USD 7.90 to USD 8.10 per share in the September 22, 2026 report. Sell-side estimates cited in the same report stood at USD 8.02 per share for fiscal year 2026, placing the midpoint of guidance at USD 8.00 and the consensus only USD 0.02 above that midpoint.

The valuation remains sensitive to execution because the stock carried a price-to-earnings ratio of 23.19 and a PEG ratio of 0.87 as of September 22, 2026. The reported net margin was 1.18 percent and return on equity was 13.12 percent for the latest reported period, figures that put the earnings beat alongside a relatively narrow profitability base.

Stock remains below yearly high

CVS Health traded at USD 87.73 on the NYSE on September 22, 2026, with volume of 2,853,360 shares during the cited mid-day session against an average volume of 8,212,691 shares. The USD 22.95 gap to the 52-week high of USD 110.68 shows that the earnings improvement has not returned the stock to its yearly peak.

For investors, the central comparison is between the USD 106.10 billion quarterly revenue base and the USD 7.90 to USD 8.10 fiscal-year 2026 EPS range. The next market test is whether the company can convert the 7.3 percent year-over-year revenue increase into sustained margin expansion.

NYSE price stays at USD 87.73

CVS Health stock stood at USD 87.73 on the NYSE on September 22, 2026. The same market snapshot recorded a 52-week range of USD 69.51 to USD 110.68 and market capitalization of USD 112.21 billion.

More news and analyses on CVS Health Corp. stock